|||||Parle| |---|---|---|---|---| |Contents||||| |Reference|and Administrative||Details|| |Trustee Directors'
Report||||3 —10| |Statement|ofTrustees'|Responsibilities||| |Independent|Auditors'|Report||12 —15| |Statement|of Financial|Activities||16| |Balance Sheet||||17| |Statement|ofCashflows|||18| |Notes to the Financial Statements||||19—30| |Trustees|and Directors|and Directors||AS Lyttelton|AS Lyttelton||(Chair)| |---|---|---|---|---|---|---|---| |||||C Cole|||| |||||Rev P Davis|||| |||||C Hall-Tomkin|||| |||||C Jelf|||| |||||Dr P Seviour|||| |||||C Sparks|||| |Chief Executive||||J Aizlewood|||| |Senior Management||Team||L Ali|||| |||||J Pickles|||| |||||M Trew|||| |||||G Volans|||| |Principal|Office and|Registered|Office|Broadway|Lodge||| |||||37Totterdown||Lane|| |||||Weston Super||Mare|| |||||Somerset|||| |||||BS249NN|||| |Bankers||||Lloyds Bank PLC|||| |||||15Blackheath||Village|| |||||Kidbrooke|||| |||||London|||| |||||SE39LH|||| |Solicitors||||Foot Anstey|||| |||||The Quad|||| |||||Blackbrook|Park Avenue||| |||||Blackbrook|Business Park||| |||||Taunton|||| |||||Somerset|||| |||||TA1 2PX|||| |Auditors||||Albert Goodman|||LLP| |||||Goodwood|House||| |||||Blackbrook|Park Avenue||| |||||Taunton|||| |||||Somerset|||| |||||TA1 2PX|||| ## ## ## |C|Cole:|University
Lecturer/Strategy|& Innovation|| |---|---|---|---|---| |P|Davis:|Supernumerary
Minister||| |R
P|Flack:
Gay:|Solicitor
Property
Investor and Farmer||(Resigned 23'" January 2023)
(Resigned 9'" June 2023)| |C|Hall-Tomkin|Property
Investor and Business Consultant||| |C|Jelf:|Insurance
Broker||| |S|Lyttelton|Music Curator and Consultant||(Chair ofTrustees)| |P|Seviour:|Retired GP||| |C|Sparks:|Retired Nurse||| ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## |||||Unres-|Res-||Unres-|Res-|| |---|---|---|---|---|---|---|---|---|---| ||||Notes|tricted
p|tricted|Total 2023
8|tricted|tricted
f|Total 2022
F| |Income:|||||||||| |Grants, donations|||||||||| |and legacies|||2|151,209|7,000|158,209|147,985|74,122|222,107| |Charitable
activities|||3|2,031,733|236,087|2,267,820|1,691,254|-|1,691,254| |Exchange
gain||||125|-|125|||| |Total income||||2,183,067|243,087|2,426,154|1,839,239|74,122|1,913,361| |Expenditure:|||||||||| |Raising funds|||4|645||645|||| |Interest paid||||30,664||30,664|6,412||6,412| |Charitable
activities|||5|2,126,716|228,417|2,355,133|1,991,856|74,122|2,065,978| |Total expenditure||||2,158,025|228,417|2,386,442|1,998,268|74,122|2,072,390| |Net incomel|||||||||| |(expenditure)for|the year|||25,042|14,670|39,712|(159,029)||(159,029)| |Transfers
between|funds||14|7,000|(7,000)||||| |Net movement
in|||||||||| |funds for the year||||32,042|7,670|39,712|(159,029)|-|(159,029)| |Reconciliation
offunds|||||||||| |Total funds brought||forward||2,316,605||2,316,605|2,475,634||2,475,634| |Total funds carried||forward||2,348,647|7,670|2,356,317|2,316,605||2,316,605| |||||2023|2022| |---|---|---|---|---|---| ||||Notes||| |Fixed assets|||||| |Tangible
fixed assets||||2,641,623|2,648,495| |||||2,641,623|2,648,495| |Current assets|||||| |Debtors|||10|144,966|166,914| |Cash at bank and|in hand|||228,162|205,391| |||||373,128|372,305| |Liabilities:|||||| |Creditors
falling due|within|one year|11|(274,440)|(258,071)| |Net current assets||||98,688|114,234| |Total assets less current||liabilities||2,740,311|2,762,729| |Creditors|||||| |Amounts
falling due|in more than one year||13|(383,994)|(446,124)| |Total net assets||||2,356,317|2,316,605| |The funds ofthe charity:|||||| |Restricted
funds|||14|7,670|| |Unrestricted
funds|||14|1,991,813|1,959,771| |Revaluation
reserve|||14|356,834|356,834| |Total charity funds||||2,356,317|2,316,605| ||||||Total 2023|Total 2022| |---|---|---|---|---|---|---| ||||||6|| |||||Notes||| |Cash flows from operating||activities||||| |Net movements
in funds for|the year||||39,712|(159,029)| |Adjustments
to cash flows from non-cash
items||||||| |Depreciation
and amortisation|||||24,823|24,217| |(Gain)/Loss
on sale ofassets||||||| |Interest paid|||||30,664|6,412| ||||||94,554|(128,400)| |Working
capital adjustments||||||| |(Increase)/decrease
in debtors||||10|21,948|(17,806)| |Increase/(decrease)
in creditors||||11|15,476|(44,693)| |Net cash flow from operations|||||131,978|(190,899)| |Cash flows from investing||activities||||| |Purchase of fixed assets|||||(17,951)|(458,435)| ||||||(17,306)|(458,435)| |Cash flows from financing||activities||||| |Interest paid|||||(30,664)|(6,412)| |Advances
of new long term|loans|||||438,521| |Repayments
of existing
long||term loans|||(61,237)|(26,646)| ||||||(91,901)|405,463| |Net increase/(decrease)
in cash and cash equivalents|||||22,771|(243,871)| |Cash and cash equivalents|at the beginning||of||205,391|449,262| |the reporting
period||||||| |Cash and cash equivalents|at the end ofthe||||228,162|205,391| |reporting
period||||||| ## ## ## ## ## ## |||Unres-
tricted|Res-
tricted|2023|Unres-es
tricted
tricted|Unres-es
tricted
tricted|2022| |---|---|---|---|---|---|---|---| |||fundsf|fundsf|Total
f|funds
f|funds
f|Total
f| |Donations|and||||||| |legacies||3,371|7,000|10,371|5,478|-|5,478| |Grants||147,838||147,838|134,169|74,122|208,291| |Exceptional|grants:||||||| |CJRS income|||||8,338|-|8,338| |||151,209|7,000|158,209|147,985|74,122|222,107| ||||Unres-
tricted|Res-
tricted|2023|Urtres-
tricted|Res-
tricted|2022| |---|---|---|---|---|---|---|---|---| ||||fundsf|funds|Total
f|funds
f|funds
f|Total
f| |Detoxification||and||||||| |residential|services||2,014,519|236,087|2,250,606|1,680,657||1,680,657| |Sundry income|||17,214|-|17,214|10,597||10,597| ||||2,031,733|236,087|2,267,820|1,691,254||1,691,254| ## ||||Unres-
tricted|Res-
tricted|2023|.
tricted|.
tricted|2022| |---|---|---|---|---|---|---|---|---| ||||funds|funds|Total|funds|funds|Total| ||||E|E|E|E|E|E| |Fundraising|||645||645|||| |Expenditure||from|charitable
activities|||||| ||||Unres-|Res-|2023|Unres-|Res-|2022| ||||tricted|tricted|Total|tricted|ricted|Total| ||||E||E|E|K|| |Staff costs|||1,653,918|228,417|1,882,335|1,578,846|73,803|1,652,649| |Household|and|||||||| |maintenance|||212,290||212,290|195,563||195,563| |Medical consumables|||20,338||20,338|21,925|200|22,125| |Patient and||||||||| |programme|||29,031||29,031|20,318|119|20,437| |Administration||costs|17,431||17,431|18,338||18,338| |Marketing
costs|||13,915||13,915|15,479||15,479| |Legal and||||||||| |professional|||142,353||142,353|122,168||122,168| |Bad debts|||37||37|(14,839)||(14,839)| |Depreciation|and|||||||| |amortisation|||24,823||24,823|24,217||24,217| |Finance charges|||5,740||5,740|3,241||3,241| |Audit fee|||6,840||6,840|6,360||6,360| |Accountancy||||||240||240| ||||2,126,716|228,417|2,355,133|1,991,856|74,122|2,065,978| ## ## |Wages and salaries||| |---|---|---| ||2023
f.|2022f| |Wages and salaries|1,560,161|1,380,454| |Social security costs|136,116|118,423| |Other pension costs|93,822|90,822| |Other staff costs|92,236|62,950| ||1,882,335|1,652,649| |The number|of employ|ees
wh|ose annual
em|oluments
were f60,000 or more were:|| |---|---|---|---|---|---| |||||2023|2022| |||||number|number| |680,000 - F89,999|||||| |Number ofemployees|||||| |The average|monthly|number|of employees|during the year was as follows:|| |||||2023|2022| |Doctors||||1|1| |Nurses and Healthcare||assistants||32|26| |Counsellors||||10|10| |Administration||||15|12| |Domestic and catering||||10|10| |||||68|59| ## ## ## |Net income|for the year before transfers||| |---|---|---|---| |||2023|2022f| |This is stated after charging:|||| |Depreciation
and amortisation||24,823|24,217| |Operating|leases|13,466|13,466| |Auditors|remuneration||| |Audit|services|6,090|5,850| |Other|services: accounting|750|750| ## |angible assets||||| |---|---|---|---|---| |||Fixtures,||| ||Freehold|Fittings and|Motor|| ||Property|Equipment|Vehicles|Total| |||E||| |Cost||||| |At 1 April 2022|2,580,357|356,804|21,978|2,959,139| |Additions||17,951||17,951| |At 31 March 2023|2,580,356|374,755|21,978|2,977,090| |Depreciation||||| |At 1 April 2022||291,362|19,282|310,644| |Charge for the year||22,127|2,696|24,823| |At 31 March 2023||313,489|21,978|335,467| |Net book value||||| |At 31 March 2023|2,580,356|61,266||2,641,623| |At 1 April 2022|2,580,357|65,442|2,696|2,648,495| ## |ost|| |---|---| |At 1 April 2022|2,223,523| |At 31 March 2023|2,223,523| |Depreciation|| |As at 1 April 2022 at 31 March 2023|| |Net book value|| |At 31 March 2023|2,223,523| |At 31 March 2022|1,802,114| ## ## |Debtors|||||| |---|---|---|---|---|---| |||||2023|2022| |Trade debtors||||97,523|100,247| |Prepayments|and accrued income|||47,443|66,667| |||||144,966|166,914| |Creditors: amounts||falling due within one year|||| |||||2023f|2022| |Trade creditors||||50,702|19,556| |Accruals and|deferred||income|151,851|167,655| |Other creditors||||9,552|9,418| |Bankloans||||62,335|61,442| |||||274,440|258,071| ## |12|Deferred income||||| |---|---|---|---|---|---| |||||2023f|2022f| ||Balance as at 1|April 2022||85,741|88,461| ||Amount
released|to income for charitable|activities|(176,674)|(117,781)| ||Amount
deferred|in year||164,574|115,061| ||Balance at 31 March 2023|||73,641|85,741| |13|Creditors: amounts
falling due in more||than one year||| ||Bank loans due
Bank loans due|( 5years
) 5years||2023f
446,329|2022f
507,566| |||||446,329|507,566| ||Less included
in|current
liabilities||(62,335)|(61,442)| |||||383,994|446,124| ## |Statement
offunds —2023|||||| |---|---|---|---|---|---| ||Opening|Incoming|Resources||Closing| ||balancef|resources
f|expended
f|Transfers
f|balancef| |Restricted funds|||||| |Donations||7,000||(7,000)|| |South West Northern|||||| |Consortium||236,087|(228,417)||7,670| |Total Restricted
Funds||243,087|(228,417)|(7,000)|7,670| |Unrestricted
funds|||||| |General|1,959,771|2,183,067|(2,158,025)|7,000|1,991,813| |Revaluation
reserve|356,834||||356,834| ||2,316,605|2,426,154|(2,386,442)||2,356,317| |Statement
offunds —2022|||||| ||Opening|Incoming|Resources||Closing| ||balance
f|resources|expended
f|Transfers
f|balancef| |Restricted funds|||||| |Infection Control Grant-|||||| |Tranche 3
Infection Control Grant-||17,009|(17,009)||| |Tranche 4||15,651|(15,651)||| |Infection Control Grant-|||||| |Tranche 5||23,159|(23,159)||| |Workforce Recruitment
and Retention
Fund||18,303|(18,303)||| |Total Restricted Funds||74,122|(74,122)||| |Unrestricted
funds|||||| |General|2,118,800|1,839,239|(1,998,268)||1,959,771| |Revaluation
reserve|356,834||||356,834| ||2,475,634|1,913,361|(2,072,390)||2,316,605| ## ## ##